Rosa Park

Rosa Park

Auto-generated profile, based on publicly available information

Rosa Park

Department of Pathology, Albert Einstein College of Medicine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2024 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
DFDavid R. Fooksman
David R. Fooksman
ZJZhixin Jing
Zhixin Jing
RPRosa Park
Rosa Park

18 June 2024 in eLife
Verified
Journal Article
Open access
ZJZhixin Jing
Zhixin Jing
PGPhillip Galbo
Phillip Galbo
LOLuis Ovando
Luis Ovando
MDMegan Demouth
Megan Demouth
SWSkylar Welte
Skylar Welte
DFDavid Fooksman
David Fooksman
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intravital two-photon imaging, we find that in contrast to most plasma cells (PCs) in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine-tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44, and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naïve mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool.

12 March 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
GJGeunhyo Jang
Geunhyo Jang
RPRosa Park
Rosa Park
EEEduardo Esteva
Eduardo Esteva
PHPei-Feng Hsu
Pei-Feng Hsu
JFJue Feng
Jue Feng
BRBoris Reizis
Boris Reizis
Leukemia-driving mutations are thought to arise in hematopoietic stem cells (HSC), yet the natural history of their spread is poorly understood. We genetically induced mutations within endogenous murine HSC and traced them in unmanipulated animals. In contrast to mutations associated with clonal hematopoiesis (such as Tet2 deletion), the leukemogenic KrasG12D mutation dramatically accelerated HSC contribution to all hematopoietic lineages. The acceleration was mediated by KrasG12D-expressing multipotent progenitors (MPP) that lacked self-renewal but showed increased proliferation and aberrant transcriptome. The deletion of osteopontin, a secreted negative regulator of stem/progenitor cells, delayed the early expansion of mutant progenitors. KrasG12D-carrying cells showed increased CXCR4-driven motility in the bone marrow, and the blockade of CXCR4 reduced the expansion of MPP in vivo. Finally, therapeutic blockade of KRASG12D spared mutant HSC but reduced the expansion of mutant MPP and their mature progeny. Thus, transforming mutations facilitate their own spread from stem cells by reprogramming MPP, creating a preleukemic state via a two-component stem/progenitor circuit.

24 August 2023 in Current Bladder Dysfunction Reports
Verified
Journal Article
Closed access
PDF file
RPRosa Park
Rosa Park
MKMelissa R. Kaufman
Melissa R. Kaufman